Cite
HARVARD Citation
Massard, C. et al. (n.d.). First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer. European journal of cancer. pp. S15-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Massard, C. et al. (n.d.). First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer. European journal of cancer. pp. S15-. [Online].